Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism

PLoS Pathogens

Volumn 8, Issue 9, 2012, Pages

  Bale, Shridhar ^a   Julien, Jean Philippe ^a   Bornholdt, Zachary A ^a   Kimberlin, Christopher R ^a,d   Halfmann, Peter ^b   Zandonatti, Michelle A ^a   Kunert, John ^b   Kroon, Gerard J A ^a   Kawaoka, Yoshihiro ^b,c   MacRae, Ian J ^a   Wilson, Ian A ^a   Saphire, Erica Ollmann ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; INTERFERON; PROTEIN VP35; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALPHA HELIX; ARTICLE; BETA SHEET; CRYSTAL STRUCTURE; ISOTHERMAL TITRATION CALORIMETRY; MARBURG VIRUS; NONHUMAN; PROTEIN RNA BINDING; PROTEIN STRUCTURE; VIRUS VIRULENCE;

CELL LINE; CRYSTALLOGRAPHY, X-RAY; EBOLAVIRUS; HEK293 CELLS; HUMANS; IMMUNE EVASION; INTERFERONS; MARBURGVIRUS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA, DOUBLE-STRANDED; RNA-BINDING PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EBOLA VIRUS; LAKE VICTORIA MARBURGVIRUS; MARBURGVIRUS; PRIMATES;

EID: 84866939048     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002916     Document Type: Article

References (49)

1. Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, et al. (2010) Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol 155: 2083-2103.
2. Martini GA, Siegert R (1971) Marburg Virus Diseas. New York: Springer.
3. Sanchez A, Geisbert TW, Feldmann H (2007) Filoviridae: Marburg and Ebola viruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA et al., editors. Fields Virology. Philadelphia: Lippincott Williams and Wilkins. pp. 1409-1448.
4. World Health Organization (2005) Marburg Hemorrhagic Fever. World Health Organization.
5. Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, et al. (1999) Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 5: 423-426.
6. Mahanty S, Gupta M, Paragas J, Bray M, Ahmed R, et al. (2003) Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection. Virology 312: 415-424.
7. Mohamadzadeh M, Chen L, Schmaljohn AL, (2007) How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 7: 556-567.
8. Barrette RW, Metwally SA, Rowland JM, Xu L, Zaki SR, et al. (2009) Discovery of swine as a host for the Reston ebolavirus. Science 325: 204-206.
9. Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, et al. (2000) Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355: 2210-2215.
10. Leung DW, Prins KC, Borek DM, Farahbakhsh M, Tufariello JM, et al. (2010) Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat Struct Mol Biol 17: 165-172.
11. Cheng A, Wong SM, Yuan YA, (2009) Structural basis for dsRNA recognition by NS1 protein of influenza A virus. Cell Res 19: 187-195.
12. Chao JA, Lee JH, Chapados BR, Debler EW, Schneemann A, et al. (2005) Dual modes of RNA-silencing suppression by Flock House virus protein B2. Nat Struct Mol Biol 12: 952-957.
13. Vargason JM, Szittya G, Burgyan J, Hall TM, (2003) Size selective recognition of siRNA by an RNA silencing suppressor. Cell 115: 799-811.
14. Hastie KM, Kimberlin CR, Zandonatti MA, MacRae IJ, Saphire EO, (2011) Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3′ to 5′ exonuclease activity essential for immune suppression. Proc Natl Acad Sci U S A 108: 2396-2401.
15. Leung DW, Prins KC, Basler CF, Amarasinghe GK, (2010) Ebolavirus VP35 is a multifunctional virulence factor. Virulence 1: 526-531.
16. Johnson RF, McCarthy SE, Godlewski PJ, Harty RN, (2006) Ebola virus VP35-VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles. J Virol 80: 5135-5144.
17. Haasnoot J, de Vries W, Geutjes EJ, Prins M, de Haan P, et al. (2007) The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog 3: e86.
18. Schumann M, Gantke T, Muhlberger E, (2009) Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J Virol 83: 8993-8997.
19. Hartman AL, Dover JE, Towner JS, Nichol ST, (2006) Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. J Virol 80: 6430-6440.
20. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Muhlberger E, et al. (2003) The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 77: 7945-7956.
21. Basler CF, Amarasinghe GK, (2009) Evasion of interferon responses by Ebola and Marburg viruses. J Interferon Cytokine Res 29: 511-520.
22. Kimberlin CR, Bornholdt ZA, Li S, Woods VL Jr, MacRae IJ, et al. (2010) Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci U S A 107: 314-319.
23. Leung DW, Ginder ND, Nix JC, Basler CF, Honzatko RB, et al. (2009) Expression, purification, crystallization and preliminary X-ray studies of the Ebola VP35 interferon inhibitory domain. Acta Crystallogr Sect F Struct Biol Cryst Commun 65: 163-165.
24. Leung DW, Ginder ND, Fulton DB, Nix J, Basler CF, et al. (2009) Structure of the Ebola VP35 interferon inhibitory domain. Proc Natl Acad Sci U S A 106: 411-416.
25. Jiang F, Ramanathan A, Miller MT, Tang GQ, Gale M Jr, et al. (2011) Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479: 423-427.
26. Luo D, Ding SC, Vela A, Kohlway A, Lindenbach BD, et al. (2011) Structural insights into RNA recognition by RIG-I. Cell 147: 409-422.
27. Li X, Ranjith-Kumar CT, Brooks MT, Dharmaiah S, Herr AB, et al. (2009) The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA. J Biol Chem 284: 13881-13891.
28. Binder M, Eberle F, Seitz S, Mucke N, Huber CM, et al. (2011) Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I). J Biol Chem 286: 27278-27287.
29. Peisley A, Lin C, Wu B, Orme-Johnson M, Liu M, et al. (2011) Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition. Proc Natl Acad Sci U S A 108: 21010-21015.
30. Rehwinkel J, Reis e Sousa C, (2010) RIGorous detection: exposing virus through RNA sensing. Science 327: 284-286.
31. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730-737.
32. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, et al. (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 101: 17264-17269.
33. Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, et al. (2011) Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147: 423-435.
34. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, et al. (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205: 1601-1610.
35. Reid SP, Cardenas WB, Basler CF, (2005) Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. Virology 341: 179-189.
36. Moller P, Pariente N, Klenk HD, Becker S, (2005) Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription. J Virol 79: 14876-14886.
37. Valmas C, Basler CF, (2011) Marburg virus VP40 antagonizes interferon signaling in a species-specific manner. J Virol 85: 4309-4317.
38. Valmas C, Grosch MN, Schumann M, Olejnik J, Martinez O, et al. (2010) Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS Pathog 6: e1000721.
39. Pflugrath JW, (1999) The finer things in X-ray diffraction data collection. Acta Crystallogr D Biol Crystallogr 55: 1718-1725.
40. Otwinowski Z, Minor W, (1997) Processing of X-ray Diffraction Data Collected in Oscillation Mode. Methods Enzymol 276A: 307-326.
41. McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ, (2005) Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr 61: 458-464.
42. Adams PD, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, et al. (2002) PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58: 1948-1954.
43. CCP4 (1994) The CCP4 Suite: Programs for X-ray Crystallography. Acta Cryst D Biol Crystallogr 50: 760-763.
44. Murshudov GN, Vagin AA, Dodson EJ, (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53: 240-255.
45. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132.
46. Wong I, Lohman TM, (1993) A double-filter method for nitrocellulose-filter binding: application to protein-nucleic acid interactions. Proc Natl Acad Sci U S A 90: 5428-5432.
47. de Azevedo WF Jr, Dias R, (2008) Experimental approaches to evaluate the thermodynamics of protein-drug interactions. Curr Drug Targets 9: 1071-1076.
48. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277-293.
49. Johnson BA, Blevins RA, (1994) NMRView, A Computer Program for the Visualization and Analysis of NMR Data. J Biomol NMR 4: 603-614.